Description
Naftopidil is an ɑ1-receptor blocker indicated for the treatment of benign prostatic hyperplasia caused by dysuria. Naftopidol reduces voiding problems, especially nocturnal frequency, thus improving patient's quality of life.
Naftopidil has a low incidence of side effects.
